Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients-Reference-Cited by-同舟云学术

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients

Published:2017-01-30 Issue:1 Volume:21 Page:
ISSN:1364-8535
Container-title:Critical Care
language:en
Short-container-title:Crit Care

Author:

Aguilar Gerardo^ORCID,Ferriols Rafael,Lozano Angels,Ezquer Carlos,Carbonell José A.,Jurado Ana,Carrizo Juan,Serralta Ferran,Puig Jaume,Navarro David,Alos Manuel,Belda F. Javier

Funder

Merck Sharp and Dohme, Spain

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13054-016-1594-9.pdf

Reference5 articles.

1. Weiler S, Seger C, Pfisterer H, et al. Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy. Antimicrob Agents Chemother. 2013;57(8):4053–7.

2. Leitner JM, Meyer B, Fuhrmann V, et al. Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration. J Antimicrob Chemother. 2011;66(4):880–4.

3. Gonzalez de Molina F, Martinez-Alberici Mde L, Ferrer R. Treatment with echinocandins during continuous renal replacement therapy. Crit Care. 2014;18(2):218.

4. Chen SC, Slavin MA, Sorrell TC. Echinocandin antifungal drugs in fungal infections: a comparison. Drugs. 2011;71:11–41.

5. Andes D, Ambrose PG, Hammel JP, et al. Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia. Antimicrob Agents Chemother. 2011;55(5):2113–21.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caspofungin sequestration in a polyacrylonitrile-derived filter: Increasing the dose does not mitigate sequestration;International Journal of Antimicrobial Agents;2023-12

2. Are we correctly treating invasive candidiasis under continuous renal replacement therapy with echinocandins? Preliminary in vitro assessment;Anaesthesia Critical Care & Pain Medicine;2021-02

3. Elimination of fluconazole during continuous renal replacement therapy. An in vitro assessment;The International Journal of Artificial Organs;2020-11-21

4. Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients;Antimicrobial Agents and Chemotherapy;2020-08-20

5. Nonstationary Pharmacokinetics of Caspofungin in ICU Patients;Antimicrobial Agents and Chemotherapy;2020-08-20